Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kyndryl Holdings (KD) Cash & Equivalents (2020 - 2025)

Kyndryl Holdings' Cash & Equivalents history spans 6 years, with the latest figure at $1.3 billion for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents fell 10.43% year-over-year to $1.3 billion, compared with a TTM value of $1.3 billion through Dec 2025, down 10.43%, and an annual FY2025 reading of $1.8 billion, up 14.93% over the prior year.
  • Cash & Equivalents for Q4 2025 was $1.3 billion at Kyndryl Holdings, up from $1.3 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $2.2 billion in Q4 2021, with the low at $43.0 million in Q2 2021.
  • Average Cash & Equivalents over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2023.
  • Year-over-year, Cash & Equivalents skyrocketed 5794.74% in 2021 and then decreased 25.72% in 2023.
  • Tracing KD's Cash & Equivalents over 5 years: stood at $2.2 billion in 2021, then dropped by 10.0% to $2.0 billion in 2022, then dropped by 16.12% to $1.7 billion in 2023, then dropped by 11.0% to $1.5 billion in 2024, then decreased by 10.43% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for KD's Cash & Equivalents are $1.3 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.5 billion (Q2 2025).